🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchClinicalTrials.gov GLP-1 trial tracker — updated weekly Page 6

ClinicalTrials.gov GLP-1 trial tracker — updated weekly

TrialTracker_MD Mon, Feb 26, 2024 at 4:00 PM 411 replies 11,865 viewsPage 6 of 20
BariatricNurseD
Senior Member
1,678
7,234
Feb 2024
Dallas, TX
Online
May 1, 2024 at 7:40 PM#26

Adding the clinical framing, because it changes how the question reads. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

33 6tony_orlando, Dr.NephBHM_UK, kim_atl_prep and 30 others
Reply Quote Save Share Report
mia_MS2
New Member
8
23
Jun 2026
Ann Arbor, MI
May 10, 2024 at 9:52 AM#27
BariatricNurseD said:
It helps to say which part of this you are uncertain about.

Same experience, arrived at from the opposite direction. Posting only so the count is not one.

34 7FDA_TrackerJim, ricardo_MIA, BrianDallas92 and 31 others
Reply Quote Save Share Report
GenomicsKate
Member
345
1,890
Oct 2024
Cambridge, MA
May 18, 2024 at 11:59 PM#28
BariatricNurseD said:
It helps to say which part of this you are uncertain about.

Adding the part of the answer the thread has not reached. Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third retelling.

35 8MarkLI_maint, Dr.PeteFamMed, claudia_zurich and 32 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
josh_phd_bmore
Member
389
1,678
Jul 2024
Baltimore, MD
May 27, 2024 at 2:01 PM#29

Adding the numbers, since they settle part of this. One habit that pays for itself: post the method alongside the number. A figure without its method cannot be checked, and an unchecked figure is how this community accumulates folklore.

That is the short version; the long version is somebody else's post.

Last edited: May 27, 2024 at 4:01 PM
36 9KarenAZ_mom, zoe_NC, Dr.ObesityLA and 33 others
Reply Quote Save Share Report
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Jun 5, 2024 at 3:58 AM#30

OP back with an update, since a thread like this is useless without one.

Update — my curve sits below the published mean and the explanation is that the trial arm had support I do not have. That was reassuring rather than otherwise.

8 6lori_vegas, Dr.PulmRoch, maya_sedona and 5 others
Reply Quote Save Share Report
14567820

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register